ScholarIQanswers from OpenAlex & ORCID
Renato Mantegazza
ResearcherPublications, citations & collaboration network
Renato Mantegazza is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Renato Mantegazza have?
ScholarIQindexed works
Renato Mantegazza has 534 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Renato Mantegazza have?
ScholarIQcitation count
Renato Mantegazza has 16,696 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Renato Mantegazza?
ScholarIQh-index
Renato Mantegazza has an h-index of 66 in OpenAlex.
What is the i10-index of Renato Mantegazza?
ScholarIQi10-index
Renato Mantegazza has an i10-index of 271 in OpenAlex.
What is the ORCID of Renato Mantegazza?
ScholarIQorcid
The ORCID for Renato Mantegazza is on the source record.
What is the OpenAlex record for Renato Mantegazza?
ScholarIQopenalex
The OpenAlex for Renato Mantegazza is on the source record.
What are the most-cited papers on Renato Mantegazza?
ScholarIQmost cited works
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
James F. Howard, Kimiaki Utsugisawa, Michael Benatar, Hiroyuki Murai, Richard J. Barohn, Isabel Illa, Saiju Jacob, John Vissing, Ted M. Burns, John T. Kissel, Srikanth Muppidi, Richard J. Nowak, Fanny O’Brien, Jingjing Wang, Renato Mantegazza, Claudio Mazia, Miguel Wilken, Carolina Ortea, Juliet Saba, Marcelo Rugiero, Mariela Bettini, Gonzalo Vidal, Alejandra Dalila Garcia, Phillipa J. Lamont, Wai-Kuen Leong, Heidi Boterhoven, Beverly Fyfe, L. Jackson Roberts, Mahi Jasinarachchi, Natasha Willlems, Julia Wanschitz, Wolfgang N. Löscher, Jan De Bleecker, Guy Van den Abeele, Kathy de Koning, Katrien De Mey, Rudy Mercelis, Linda Wagemaekers, Délphine Mahieu, Philip Van Damme, Charlotte Smetcoren, Olivier Stevens, Sarah Verjans, Ann D’Hondt, Petra Tilkin, Alzira Alves de Siqueira Carvalho, Rosa Hasan, Igor Dias Brockhausen, David Feder, Daniel Ambrosio, Ana Paula Souto Melo, Rosana Rocha, Bruno Bezerra Rosa, Thabata Veiga, Luiz Augusto da Silva, Jordana Gonçalves Geraldo, Maria da Penha Morita Ananias, Érica Nogueira Coelho, Gabriel Pina Paiva, M Tovar Pozo, Natália Prando, Debora Dada Martineli Torres, Cristiani Fernanda Butinhao, Érica Nogueira Coelho, Luciana Renata Cubas Volpe, Gustavo Duran, Tamires Cristina Gomes da Silva, Luiz Otavio Maia Gonçalves, Lucas Eduardo Pazetto, Luciana Souza Duca, Tomás Augusto Suriane Fialho, Maurício Friedrich, Alexandre Guerreiro, Henrique Mohr, Maurer Pereira Martins, Daiane da Cruz Pacheco, Ana Paula Macagnan, Aline de Cassia Santos, Acary Souza Bullé Oliveira, Ana Carolina Amaral de Andrade, Marcelo Annes, Valéria Cavalcante Lino, Wladimir Bocca Vieira de Rezende Pinto, Carolina Miranda, Fernanda Carrara, Iandra Souza, Angela Genge, Rami Massie, Natasha Campbell, Vera Bril, Hans Katzberg, Mehran Soltani, Eduardo Ng, Zaeem A. Siddiqi, Celile Phan, Derrick Blackmore, Stanislav Voháňka, Josef Bednařík, Magda Chmelikova, Marek Čierny
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
James F. Howard, Vera Bril, Tuan Vu, Chafic Karam, Stojan Perić, Temur Margania, Hiroyuki Murai, Małgorzata Bilińska, R Shakarishvili, Marek Śmiłowski, Antonio Guglietta, Peter Ulrichts, Tony Vangeneugden, Kimiaki Utsugisawa, Jan J.G.M. Verschuuren, Renato Mantegazza, Jan L. De Bleecker, Kathy de Koning, Katrien De Mey, Annelien De Pue, R. Mercelis, Maren Wyckmans, Caroline Vinck, Linda Wagemaekers, Jonathan Baets, Eduardo Ng, Jafar Shabanpour, Lubna Daniyal, Shabber Mannan, Hans Katzberg, Angela Genge, Zaeem A. Siddiqi, Jana Junkerová, Jana Hořáková, Katerina Reguliova, Michaela Týblová, Ivana Jurajdova, Iveta Nováková, Michala Jakubíková, Jiří Piťha, Stanislav Voháňka, Katerina Havelkova, Tomáš Horák, Josef Bednařík, Mageda Horakova, Andreas Meisel, Dike Remstedt, Claudia Heibutzki, Siegfried Köhler, Lea Gerischer, Sarah Hoffman, Frauke Stascheit, John Vissing, Lizzie Zafirakos, Kuldeep Kumar Khatri, Anne Ostergaard Autzen, Mads Stemmerik, Henning Andersen, Shahram Attarian, Emmanuelle Salort‐Campana, Émilien Delmont, Aude‐Marie Grapperon, Ludivine Kouton, Alexander Tsiskaridze, Csilla Rózsa, Gedeonne Jakab, Szilvia Z. Tóth, G Szabó, David Bors, Enikő Szabó, Angela Campanella, Fiammetta Vanoli, Rita Frangiamore, Carlo Antozzi, Silvia Bonanno, Lorenzo Maggi, Riccardo Giossi, Francesco Saccà, Angela Marsili, Chiara Pane, Giorgia Puorro, Antonio Reia, Giovanni Antonini, Girolamo Alfieri, Stefania Morino, Matteo Garibaldi, Laura Fionda, Luca Leonardi, Shingo Konno, Akiyuki Uzawa, Kaoru Sakuma, Chiho Watanabe, Yukiko Ozawa, Manato Yasuda, Yosuke Onishi, Makoto Samukawa, Tomoko Tsuda, Yasushi Suzuki, Sayaka Ishida, Genya Watanabe
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
James F. Howard, Saskia Bresch, Angela Genge, Channa Hewamadduma, John L. Hinton, Yessar Hussain, Raúl Juntas‐Morales, Henry J. Kaminski, Angelina Maniaol, Renato Mantegazza, Masayuki Masuda, Kumaraswamy Sivakumar, Marek Śmiłowski, Kimiaki Utsugisawa, Tuan Vu, Michael D. Weiss, Małgorzata Zajda, Babak Boroojerdi, Melissa Brock, Guillemette de la Borderie, Petra W. Duda, Romana Lowcock, Mark Vanderkelen, Maria Isabel Leite, Dylan Sembinelli, Jeanne Teitelbaum, Michael Nicolle, E Bernard, Juliette Svahn, Marco Spinazzi, Tanya Stojkovic, Sophie Demeret, Nicolas Weiss, Loïc Le Guennec, Sihame Messai, Christine Tranchant, Aleksandra Nadaj‐Pakleza, Jean‐Baptiste Chanson, Muhtadi Suliman, Leila Zaidi, Céline Tard, Peggy Lecointe, Jana Zschüntzsch, Jens Schmidt, Stefanie Glaubitz, Rachel Zeng, Matthias Scholl, Markus C. Kowarik, Ulf Ziemann, Markus Krumbholz, Pascal Martin, Christoph Ruschil, Jutta Dünschede, Roswitha Kemmner, Natalie Rumpel, Benjamin Berger, Andreas Totzeck, Tim Hagenacker, Benjamin Stolte, Raffaele Iorio, Amelia Evoli, Silvia Falso, Carlo Antozzi, Rita Frangiamore, Fiammetta Vanoli, Elena Rinaldi, Kazushi Deguchi, Naoya Minami, Yuriko Nagane, Yasushi Suzuki, Sayaka Ishida, Shigeaki Suzuki, Jin Nakahara, Astushi Nagaoka, Shunsuke Yoshimura, Shingo Konno, Youko Tsuya, Akiyuki Uzawa, Tomoya Kubota, Masanori Takahashi, Tatsusada Okuno, Hiroyuki Murai, Nils Erik Gilhus, Marion Boldingh, Tone Hakvåg Rønning, Urszula Chyrchel-Paszkiewicz, Klaudiusz Kumor, Tomasz Zieliński, Krzysztof Banaszkiewicz, Michał Błaż, Agata Kłósek, Mariola Matysiak, Andrzej Szczudlik, Aneta Paśko, L Szczechowski, Marta Banach, Jan Ilkowski, S. Kapetanovic García, Patricia Ortiz Bagan, Ana Belén Cánovas Segura
Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis
Srikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, Hiroyuki Murai, Richard J. Barohn, Isabel Illa, Saiju Jacob, John Vissing, Ted M. Burns, John T. Kissel, Richard J. Nowak, Henning Andersen, Carlos Casasnovas, Jan L. De Bleecker, Tuan Vu, Renato Mantegazza, Fanny O’Brien, Jing Jing Wang, Kenji P. Fujita, James F. Howard, for the Regain Study Group